These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5591516)

  • 21. The metabolism of tritiated dopamine in regions of the rat brain in vivo. II. The significance of the neutral metabolites of catecholamines.
    Taylor KM; Laverty R
    J Neurochem; 1969 Sep; 16(9):1367-76. PubMed ID: 5817555
    [No Abstract]   [Full Text] [Related]  

  • 22. Dopamine and noradrenaline transport into subcellular vesicles of the striatum.
    Philippu A; Beyer J
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 278(4):387-402. PubMed ID: 4269971
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons.
    Besson MJ; Cheramy A; Glowinski J
    Eur J Pharmacol; 1969 Jul; 7(1):111-4. PubMed ID: 5821798
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug-induced release of 3H-norepinephrine and 3H-serotonin from brain slices.
    Ng KY; Chase TN; Kopin IJ
    Nature; 1970 Oct; 228(5270):468-9. PubMed ID: 5482502
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
    Eisenhofer G; Hovevey-Sion D; Kopin IJ; Miletich R; Kirk KL; Finn R; Goldstein DS
    J Pharmacol Exp Ther; 1989 Jan; 248(1):419-27. PubMed ID: 2563292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
    Carlsson A; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
    [No Abstract]   [Full Text] [Related]  

  • 27. Blockade of the nicotine-induced norepinephrine release by cocaine, phenoxybenzamine and desipramine.
    Su C; Bevan JA
    J Pharmacol Exp Ther; 1970 Nov; 175(2):533-40. PubMed ID: 5481718
    [No Abstract]   [Full Text] [Related]  

  • 28. Cocaine and desipramine antagonize the clonidine-induced inhibition of [3H]-noradrenaline release from the rat cerebral cortex [proceedings].
    Dubocovich ML; Langer SZ; Pelayo F
    Br J Pharmacol; 1979 Nov; 67(3):417P-418P. PubMed ID: 497546
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of 6-hydroxydopamine and reserpine on amphetamine-induced release of norepinephrine in rat cerebral cortex.
    Kalisker A; Waymire JC; Rutledge CO
    J Pharmacol Exp Ther; 1975 Apr; 193(1):64-72. PubMed ID: 237115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations.
    Florin SM; Kuczenski R; Segal DS
    J Pharmacol Exp Ther; 1995 Jul; 274(1):231-41. PubMed ID: 7616403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine.
    Carlsson A; Lindqvist M
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):112-20. PubMed ID: 6013085
    [No Abstract]   [Full Text] [Related]  

  • 33. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on uptake mechanisms in central monoamine neurones.
    Fuxe K; Hökfelt T; Ungerstedt U
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:8. PubMed ID: 5630972
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of amine uptake in tubero-infundibular dopamine neurones and in catecholamine cell bodies of the area postrema.
    Fuxe K; Hamberger B; Malmfores T
    J Pharm Pharmacol; 1966 Aug; 18(8):543-4. PubMed ID: 4381861
    [No Abstract]   [Full Text] [Related]  

  • 36. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the role of rate of brain norepinephrine release in the antibenzoquinolizine action of desipramine.
    Sulser F; Soroko F
    Psychopharmacologia; 1965 Sep; 8(3):191-200. PubMed ID: 5885875
    [No Abstract]   [Full Text] [Related]  

  • 38. Tricyclic antidepressants: evidence for an intraneuronal site of action.
    Reid WD; Stefano FJ; Kurzepa S; Brodie BB
    Science; 1969 Apr; 164(3878):437-9. PubMed ID: 5777215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amphetamine on urinary and tissue catecholamines in rats after inhibition of its metabolism with desmethylimipramine.
    Lewander T
    Eur J Pharmacol; 1968 Dec; 5(1):1-9. PubMed ID: 5718514
    [No Abstract]   [Full Text] [Related]  

  • 40. Cocaine and phencyclidine. Heterogenous dopaminergic interactions with tetrabenazine.
    Bagchi SP
    Neuropharmacology; 1985 Jan; 24(1):37-41. PubMed ID: 3982601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.